Brief: RxSight Says Mark Wilterding Appointed As CFO Effective Jan 11, 2026
11/01/2026 14:36
Jan 11 (Reuters) - Rxsight Inc RXST.O: RXSIGHT, INC. ANNOUNCES PRELIMINARY Q4 AND 2025 FINANCIAL RESULTS; NEW CHIEF FINANCIAL OFFICER RXSIGHT Q4 REVENUE USD 32.6 MILLION VS. IBES ESTIMATE USD 28.6 MILLION Source text: ID:nGNXz4kB2 Further company coverage: RXST.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on RxSight
See all newsUS RESEARCH ROUNDUP-Boeing, Twilio, WP Carey
Eye care company Alcon raises margin outlook, shares jump (updated)
RxSight, Inc. reports results for the quarter ended June 30 - Earnings Summary
RxSight Q2 adjusted loss beats estimates; withdraws 2026 guidance
Brief: Rxsight Inc Q2 Operating Expenses USD 39.7 Million